Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer. [electronic resource]
Producer: 20101230Description: 571-7 p. digitalISSN:- 1559-131X
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Carcinoma -- drug therapy
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Disease-Free Survival
- Docetaxel
- Doxorubicin -- administration & dosage
- Estrogens
- Female
- Genes, erbB-2
- Humans
- Kaplan-Meier Estimate
- Lymphatic Metastasis
- Mastectomy, Modified Radical
- Mastectomy, Segmental
- Middle Aged
- Neoadjuvant Therapy
- Neoplasms, Hormone-Dependent -- drug therapy
- Progesterone
- Prospective Studies
- Radiotherapy, Adjuvant
- Tamoxifen -- administration & dosage
- Taxoids -- administration & dosage
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.